Crossmark

Efficacy of Intravenous Hydroxocobalamin for Treatment of Sodium Methanethiolate Exposure in a Swine Model (Sus scrofa) of Severe Methanethiol Toxicity

Crossref DOI link: https://doi.org/10.1007/s13181-020-00767-7

Published Online: 2020-04-01

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maddry, Joseph K. https://orcid.org/0000-0002-8341-4182
Paredes, R. Madelaine

Rebeles, Jennifer

Olson, Glen

Castaneda, Maria

Canellis, Kaysie

Ng, Patrick C.

Bebarta, Vikhyat S.
Funding

Funding for this research was provided by:

Air Force Surgeon General
License Information

Text and Data Mining valid from 2020-04-01

Version of Record valid from 2020-04-01
More Information

Article History

Received: 22 November 2019

Revised: 18 February 2020

Accepted: 21 February 2020

First Online: 1 April 2020

Compliance with Ethical Standards

: The protocol was approved by the 59th Medical Wing (MDW) Institutional Animal Care and Use Committee (IACUC). The study was conducted in accordance with the regulations and guidelines of the Animal Welfare Act, the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and the American Association for the Accreditation of Laboratory Animal Care.

: The views expressed are those of the authors and do not reflect the official views or policy of the Department of Defense or its Components.

: None.

Document is current

Any future updates will be listed below